News

‘There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes game-changing $2 billion deal for new obesity d…
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Obesity drug boom has a new pecking order
The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...
Ozempic copies restricted after US judge deni
April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...
The Best Stock to Buy With Less Than $60 in the Market Sell-Off
One such example is Novo Nordisk ( NVO 2.01%), the Denmark-based pharmaceutical leader whose shares are exchanging hands for just $60 each, and as recently as last July, traded in the mid-140s. Novo ...
WeightWatchers to file for bankruptcy within weeks as it battles $1.6b in debts
WeightWatchers will file for bankruptcy in the coming weeks after finally negotiating a deal on its $1.6 billion of debt.
US judge denies injunction, restricts copies of weight-loss drug Ozempic
A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and ...
Ozempic copies restricted after US judge denies injunction
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...
Eli Lilly Stock Soars on Weight-Loss News. Why It’s Bad for Novo Nordisk.
Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...